$ARTL
ARTELO BIOSCIENCES, INC.

2024 Q3 Form 10-Q Financial Statement

#000164033424001221 Filed on August 13, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $870.0K $827.0K
YoY Change -15.53% -19.86%
% of Gross Profit
Research & Development $325.0K $1.685M
YoY Change -79.5% 124.07%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $1.195M $2.512M
YoY Change -54.28% 40.81%
Operating Profit -$1.195M -$2.512M
YoY Change -54.28% 40.81%
Interest Expense $63.00K $79.00K
YoY Change -57.3%
% of Operating Profit
Other Income/Expense, Net $63.00K $79.00K
YoY Change -61.82% -57.3%
Pretax Income -$1.132M -$2.433M
YoY Change -53.8% 52.16%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$1.132M -$2.433M
YoY Change -53.78% 52.16%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$0.35 -$0.75
COMMON SHARES
Basic Shares Outstanding 3.228M shares 3.228M shares
Diluted Shares Outstanding 3.228M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.857M $5.602M
YoY Change 84.05% -2.05%
Cash & Equivalents $4.357M $881.0K
Short-Term Investments $500.0K $4.721M
Other Short-Term Assets $129.0K $566.0K
YoY Change -76.96% -7.36%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $4.986M $6.168M
YoY Change -62.87% -57.76%
LONG-TERM ASSETS
Property, Plant & Equipment $108.0K $116.0K
YoY Change 260.0% 197.44%
Goodwill
YoY Change
Intangibles $2.039M $2.039M
YoY Change 0.0% 0.0%
Long-Term Investments
YoY Change
Other Assets $3.000K $3.000K
YoY Change -98.48%
Total Long-Term Assets $2.150M $2.158M
YoY Change 3.81% -5.14%
TOTAL ASSETS
Total Short-Term Assets $4.986M $6.168M
Total Long-Term Assets $2.150M $2.158M
Total Assets $7.136M $8.326M
YoY Change -53.96% -50.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $627.0K $863.0K
YoY Change -25.36% 65.01%
Accrued Expenses $34.00K $33.00K
YoY Change 13.33% -2.94%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $697.0K $940.0K
YoY Change -24.32% 55.89%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $78.00K $87.00K
YoY Change 1350.0%
Total Long-Term Liabilities $78.00K $87.00K
YoY Change 1350.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $697.0K $940.0K
Total Long-Term Liabilities $78.00K $87.00K
Total Liabilities $775.0K $1.027M
YoY Change -15.85% 68.64%
SHAREHOLDERS EQUITY
Retained Earnings -$46.36M -$45.23M
YoY Change 24.49% 30.0%
Common Stock $3.000K $3.000K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $6.361M $7.299M
YoY Change
Total Liabilities & Shareholders Equity $7.136M $8.326M
YoY Change -53.96% -50.67%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$1.132M -$2.433M
YoY Change -53.78% 52.16%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$778.0K -$2.063M
YoY Change -56.78% 27.11%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $4.250M $1.750M
YoY Change -332.24% 338.6%
Cash From Investing Activities $4.250M $1.750M
YoY Change -332.24% 338.6%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -778.0K -2.063M
Cash From Investing Activities 4.250M 1.750M
Cash From Financing Activities 0.000 0.000
Net Change In Cash 3.472M -313.0K
YoY Change -212.36% -74.43%
FREE CASH FLOW
Cash From Operating Activities -$778.0K -$2.063M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3188959 shares
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1599000 usd
us-gaap Net Income Loss
NetIncomeLoss
-4916000 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001621221
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
416667 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3188959 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3227700 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38951
dei Entity Registrant Name
EntityRegistrantName
ARTELO BIOSCIENCES, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-1220924
dei Entity Address Address Line1
EntityAddressAddressLine1
505 Lomas Santa Fe
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 160
dei Entity Address City Or Town
EntityAddressCityOrTown
Solana Beach
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Country
EntityAddressCountry
US
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92075
dei City Area Code
CityAreaCode
858
dei Local Phone Number
LocalPhoneNumber
925-7049
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
dei Trading Symbol
TradingSymbol
ARTL
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3227700 shares
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
881000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2815000 usd
CY2024Q2 us-gaap Marketable Securities
MarketableSecurities
4721000 usd
CY2023Q4 us-gaap Marketable Securities
MarketableSecurities
7611000 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
566000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
554000 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
6168000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
10980000 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
116000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
21000 usd
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2039000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2039000 usd
CY2024Q2 us-gaap Other Assets
OtherAssets
3000 usd
CY2023Q4 us-gaap Other Assets
OtherAssets
3000 usd
CY2024Q2 us-gaap Assets
Assets
8326000 usd
CY2023Q4 us-gaap Assets
Assets
13043000 usd
CY2024Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
863000 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1238000 usd
CY2024Q2 artl Due To Related Parties
DueToRelatedParties
44000 usd
CY2023Q4 artl Due To Related Parties
DueToRelatedParties
30000 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
33000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
23000 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
940000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1291000 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
87000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
0 usd
CY2024Q2 us-gaap Liabilities
Liabilities
1027000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
1291000 usd
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
3000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
3000 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
52725000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
52262000 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-45226000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-40310000 usd
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-203000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-203000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
7299000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
11752000 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8326000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13043000 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
827000 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1032000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1909000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2089000 usd
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1685000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
752000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3192000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1987000 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
2512000 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
1784000 usd
us-gaap Operating Expenses
OperatingExpenses
5101000 usd
us-gaap Operating Expenses
OperatingExpenses
4076000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2512000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1784000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-5101000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-4076000 usd
CY2024Q2 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
79000 usd
CY2023Q2 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
185000 usd
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
185000 usd
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
309000 usd
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
79000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
185000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
185000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
309000 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-2433000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3767000 usd
CY2024Q2 us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
0 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
-29000 usd
us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
0 usd
us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
0 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
33000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
53000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
4000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
53000 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2433000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1595000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4916000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3714000 usd
CY2024Q2 artl Earnings Per Share Basics And Diluted
EarningsPerShareBasicsAndDiluted
-0.75
CY2023Q2 artl Earnings Per Share Basics And Diluted
EarningsPerShareBasicsAndDiluted
-0.56
artl Earnings Per Share Basics And Diluted
EarningsPerShareBasicsAndDiluted
-1.53
artl Earnings Per Share Basics And Diluted
EarningsPerShareBasicsAndDiluted
-1.32
CY2024Q2 artl Weighted Average Number Of Share Outstanding Basics And Diluted
WeightedAverageNumberOfShareOutstandingBasicsAndDiluted
3228000 shares
CY2023Q2 artl Weighted Average Number Of Share Outstanding Basics And Diluted
WeightedAverageNumberOfShareOutstandingBasicsAndDiluted
2856000 shares
artl Weighted Average Number Of Share Outstanding Basics And Diluted
WeightedAverageNumberOfShareOutstandingBasicsAndDiluted
3213000 shares
artl Weighted Average Number Of Share Outstanding Basics And Diluted
WeightedAverageNumberOfShareOutstandingBasicsAndDiluted
2856000 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
11752000 usd
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
55000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
213000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-2483000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
9537000 usd
CY2024Q2 us-gaap Share Based Compensation
ShareBasedCompensation
195000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-2433000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
7299000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
19403000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
354000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-2168000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
49000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
17638000 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
225000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1599000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
4000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
16268000 usd
us-gaap Profit Loss
ProfitLoss
4916000 usd
us-gaap Profit Loss
ProfitLoss
3767000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
408000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
579000 usd
artl Fair Value Of Trading Marketable Securities
FairValueOfTradingMarketableSecurities
185000 usd
artl Fair Value Of Trading Marketable Securities
FairValueOfTradingMarketableSecurities
309000 usd
us-gaap Other Noncash Expense
OtherNoncashExpense
16000 usd
us-gaap Other Noncash Expense
OtherNoncashExpense
21000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-40000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-101000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-368000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-402000 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
14000 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-9000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-14000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-23000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5005000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3809000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
481000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
8154000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
3500000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
9240000 usd
artl Proceeds From Disposition Of Available For Sale Securities
ProceedsFromDispositionOfAvailableForSaleSecurities
0 usd
artl Proceeds From Disposition Of Available For Sale Securities
ProceedsFromDispositionOfAvailableForSaleSecurities
1512000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3019000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2598000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
55000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
55000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-3000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
42000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1934000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1169000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2815000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6888000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
881000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5719000 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
artl Non Cash Transaction Initial Recognition Of The Right Of Use Asset And Lease Liability
NonCashTransactionInitialRecognitionOfTheRightOfUseAssetAndLeaseLiability
111000 usd
artl Non Cash Transaction Initial Recognition Of The Right Of Use Asset And Lease Liability
NonCashTransactionInitialRecognitionOfTheRightOfUseAssetAndLeaseLiability
0 usd

Files In Submission

Name View Source Status
0001640334-24-001221-index-headers.html Edgar Link pending
0001640334-24-001221-index.html Edgar Link pending
0001640334-24-001221.txt Edgar Link pending
0001640334-24-001221-xbrl.zip Edgar Link pending
artl-20240630.xsd Edgar Link pending
artl_10q.htm Edgar Link pending
artl_ex311.htm Edgar Link pending
artl_ex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
artl-20240630_cal.xml Edgar Link unprocessable
artl-20240630_def.xml Edgar Link unprocessable
artl-20240630_lab.xml Edgar Link unprocessable
artl-20240630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
artl_10q_htm.xml Edgar Link completed
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending